Gao HF, Ye GL, Lin Y, Huang Q, et al. Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial. J Clin Oncol 2026 Jan 23:JCO2502176. doi: 10.1200/JCO-25-02176.
PMID: 41576297